| Page 1467 | Kisaco Research
 

Christophe Carrié

Chief Executive Officer
Matmatch GmbH

Christophe Carrié started working for Plansee in Austria in 2007 in sales of molybdenum and tungsten-based materials. From 2010 he spent 5 years as Key Account Manager Europe for Plansee in the Power Transmission and Distribution business unit before being appointed Product Development Manager Europe in 2015. In 2017 he became Head of Business Development. In 2021 he joined Matmatch as CEO, based in Munich, Germany

Christophe Carrié

Chief Executive Officer
Matmatch GmbH

Christophe Carrié

Chief Executive Officer
Matmatch GmbH

Christophe Carrié started working for Plansee in Austria in 2007 in sales of molybdenum and tungsten-based materials. From 2010 he spent 5 years as Key Account Manager Europe for Plansee in the Power Transmission and Distribution business unit before being appointed Product Development Manager Europe in 2015. In 2017 he became Head of Business Development. In 2021 he joined Matmatch as CEO, based in Munich, Germany

 

Oliver Peoples

CEO
Yield10 Bioscience

Oliver P. Peoples, Ph.D. is the President and Chief Executive Officer of Yield10 Bioscience. Previously, Dr. Peoples was a co-founder of Metabolix and served as its Chief Scientific Officer and Vice President of Research and Development from January 2000 until October 2016, and also served as director of the Company since June 1992.

Oliver Peoples

CEO
Yield10 Bioscience

Oliver Peoples

CEO
Yield10 Bioscience

Oliver P. Peoples, Ph.D. is the President and Chief Executive Officer of Yield10 Bioscience. Previously, Dr. Peoples was a co-founder of Metabolix and served as its Chief Scientific Officer and Vice President of Research and Development from January 2000 until October 2016, and also served as director of the Company since June 1992.

Prior to founding Metabolix, Dr. Peoples was a research scientist with the Department of Biology at the Massachusetts Institute of Technology where he emerged as a pioneer of the new field of metabolic pathway engineering and its applications in industrial biotechnology. The research carried out by Dr. Peoples at MIT established the fundamental tools and methods for engineering bacteria and plants to produce Mirel biopolymers. Dr. Peoples has published numerous peer reviewed academic papers and is an inventor of over 90 patents and patent applications worldwide. Dr. Peoples received a Ph.D. in Molecular Biology from the University of Aberdeen, Scotland.

 

Sharon Donovan

Professor and Director of Personalized Nutrition Initiative
University of Illinois at Urbana-Champaign

Sharon Donovan

Professor and Director of Personalized Nutrition Initiative
University of Illinois at Urbana-Champaign

Sharon Donovan

Professor and Director of Personalized Nutrition Initiative
University of Illinois at Urbana-Champaign
 

Helen Messier

Chief Medical Officer
Tailored Script

Helen Messier

Chief Medical Officer
Tailored Script

Helen Messier

Chief Medical Officer
Tailored Script
 

Gil Blander

Co-Founder & Chief Scientific Officer
InsideTracker

Gil Blander

Co-Founder & Chief Scientific Officer
InsideTracker

Gil Blander

Co-Founder & Chief Scientific Officer
InsideTracker
 

Stelios Diamantidis

Senior Director, Artificial Intelligence Solutions, Office of the COO
Synopsys

Stelios Diamantidis

Senior Director, Artificial Intelligence Solutions, Office of the COO
Synopsys

Stelios Diamantidis

Senior Director, Artificial Intelligence Solutions, Office of the COO
Synopsys
 

Silvia Boschetto

Director/ Founder
Silvakey

Silvia Boschetto

Director/ Founder
Silvakey

Silvia Boschetto

Director/ Founder
Silvakey
 

Julian Haspel

Head of e-Powertrain Group
LANXESS Deutschland GmbH

Julian Haspel

Head of e-Powertrain Group
LANXESS Deutschland GmbH

Julian Haspel

Head of e-Powertrain Group
LANXESS Deutschland GmbH